GAMMA Investing LLC Boosts Position in Option Care Health, Inc. (NASDAQ:OPCH)

GAMMA Investing LLC grew its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 14,129.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 111,560 shares of the company's stock after buying an additional 110,776 shares during the quarter. GAMMA Investing LLC owned 0.07% of Option Care Health worth $3,899,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Rhumbline Advisers grew its stake in Option Care Health by 3.3% during the 4th quarter. Rhumbline Advisers now owns 564,518 shares of the company's stock worth $13,097,000 after purchasing an additional 18,237 shares in the last quarter. Villere ST Denis J & Co. LLC grew its holdings in Option Care Health by 18.5% during the 4th quarter. Villere ST Denis J & Co. LLC now owns 1,344,608 shares of the company's stock worth $31,195,000 after acquiring an additional 209,502 shares in the last quarter. State of New Jersey Common Pension Fund D increased its position in shares of Option Care Health by 52.1% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 96,204 shares of the company's stock valued at $2,232,000 after purchasing an additional 32,972 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of Option Care Health by 0.9% in the 4th quarter. Principal Financial Group Inc. now owns 479,255 shares of the company's stock valued at $11,119,000 after purchasing an additional 4,166 shares in the last quarter. Finally, Venturi Wealth Management LLC grew its stake in shares of Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after purchasing an additional 4,561 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

OPCH has been the subject of several recent analyst reports. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Trading Up 0.6%

Shares of OPCH traded up $0.18 during mid-day trading on Thursday, hitting $31.87. The company had a trading volume of 999,178 shares, compared to its average volume of 1,866,534. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The business's 50-day simple moving average is $32.26 and its 200-day simple moving average is $30.15. The stock has a market cap of $5.22 billion, a PE ratio of 26.78, a P/E/G ratio of 2.30 and a beta of 0.74. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Option Care Health's revenue for the quarter was up 16.3% on a year-over-year basis. During the same quarter last year, the business earned $0.26 EPS. Sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.